PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 171 filers reported holding PRECIGEN INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,875 | +30.1% | 59,067 | +5.4% | 0.00% | – |
| Q2 2023 | $64,458 | +30.5% | 56,050 | +20.3% | 0.00% | – |
| Q1 2023 | $49,382 | -21.4% | 46,587 | +12.8% | 0.00% | – |
| Q4 2022 | $62,788 | -28.3% | 41,308 | 0.0% | 0.00% | – |
| Q3 2022 | $87,573 | +78.7% | 41,308 | +13.9% | 0.00% | – |
| Q2 2022 | $49,000 | -36.4% | 36,274 | 0.0% | 0.00% | – |
| Q1 2022 | $77,000 | -43.0% | 36,274 | 0.0% | 0.00% | – |
| Q4 2021 | $135,000 | -27.0% | 36,274 | -2.1% | 0.00% | – |
| Q3 2021 | $185,000 | -23.2% | 37,036 | 0.0% | 0.00% | – |
| Q2 2021 | $241,000 | +14.8% | 37,036 | +21.6% | 0.00% | – |
| Q1 2021 | $210,000 | -28.3% | 30,460 | +6.0% | 0.00% | -100.0% |
| Q4 2020 | $293,000 | +253.0% | 28,723 | +20.7% | 0.00% | – |
| Q3 2020 | $83,000 | -33.6% | 23,791 | -5.3% | 0.00% | – |
| Q2 2020 | $125,000 | +3.3% | 25,133 | -29.4% | 0.00% | – |
| Q1 2020 | $121,000 | – | 35,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 11,243,560 | $12,930,093 | 0.72% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 3,333,468 | $3,833,488 | 0.36% |
| First Washington CORP | 592,975 | $681,921 | 0.30% |
| Fore Capital, LLC | 490,000 | $563,500 | 0.26% |
| EMFO, LLC | 180,000 | $207,000 | 0.19% |
| MSD Partners, L.P. | 960,000 | $1,104,000 | 0.10% |
| SANDERS MORRIS HARRIS LLC | 325,000 | $373,750 | 0.08% |
| Virtus ETF Advisers LLC | 87,692 | $100,846 | 0.06% |
| XTX Topco Ltd | 263,046 | $302,503 | 0.05% |
| CHIRON CAPITAL MANAGEMENT, LLC | 45,906 | $52,792 | 0.04% |